MARSHALL COCO: Open Payments
NPI 1013045624 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 4 payments from 4 companies in 2025. Trend: 2023 $510 · 2024 $346 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $112 |
| Genentech USA, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: Ozempic, Itovebi, LM Undivided, REPATHA.
Industry payments across LA — which companies pay providers there.
